Genpharmasec Ltd
BSE:531592
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.93
6.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Genpharmasec Ltd
Cost of Revenue
Genpharmasec Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Genpharmasec Ltd
BSE:531592
|
Cost of Revenue
-₹239.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-109%
|
CAGR 10-Years
N/A
|
|
|
S
|
Shree Global Tradefin Ltd
BSE:512463
|
Cost of Revenue
-₹7.2B
|
CAGR 3-Years
-863%
|
CAGR 5-Years
-124%
|
CAGR 10-Years
N/A
|
|
|
MSTC Ltd
NSE:MSTCLTD
|
Cost of Revenue
-₹651.9m
|
CAGR 3-Years
42%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
Adani Enterprises Ltd
NSE:ADANIENT
|
Cost of Revenue
-₹467B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-1%
|
|
|
Refex Industries Ltd
NSE:REFEX
|
Cost of Revenue
-₹11.9B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Indiamart Intermesh Ltd
NSE:INDIAMART
|
Cost of Revenue
-₹22.6m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Genpharmasec Ltd
Glance View
Genpharmasec Ltd. engages in manufacturing and trading in Organic and Inorganic Chemicals, Dyes and Pigments Its products include potassium hydroxide and caustic soda. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of diagnostic equipment, pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, herbs, and in pharmaceutical, medicinal, and proprietary and industrial preparations, compounds and articles of kinds, chemists, druggists, and chemical manufacturers.
See Also
What is Genpharmasec Ltd's Cost of Revenue?
Cost of Revenue
-239.6m
INR
Based on the financial report for Jun 30, 2024, Genpharmasec Ltd's Cost of Revenue amounts to -239.6m INR.
What is Genpharmasec Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-109%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Genpharmasec Ltd have been 4% over the past three years , -109% over the past five years .
You don't have any saved screeners yet
